The Weekly Scale: June 21st, 2021

This week at MarketScale, we held a major press conference on the future of retail, hosted a true legend of education, and examined what “retailtainment” will look like in 2022. That’s making my wallet cringe.

Break out the ice chests for the dog days of summer— it’s time to scale up.

Walmart launched big news this week and MarketScale had the inside track.

Retail giant Walmart recently announced a partnership with DroneUp intended to make it the premier retailer for drone deliveries and host of Drones in America joined our press conference to discuss how this puts a very real timeline on drone deliveries at scale.

Did you catch the latest installment of The Product Drop, suffice to say we were big fans.

Shain Wainscot of Portacool joined me on set as dove into what inspired their Jetstream 250 fan and why they keep American manufacturing at the center of what they do.

what is being done to reimagine the next decade of education?

Well to help answer that our very own JW Marshall, will be sitting down with EdTech legend Sal Khan of the one and only Khan Academy this Thursday! Make sure you don’t miss this incredible interview where they will be joined by AT&T’s Mylayna Albright to address what the biggest silver linings of COVID will be for EdTech.

Data collection and analysis are the lifeblood of modern organizations — and harsh edge environments can’t get in the way of actionable insights.

The Rugged Edge Survival Guide by Premio had a major live event this week that brought several key note speakers to address what your organization needs to keep in mind for XXX.

Is the future of hotels, modular? The MarketScale Hospitality Roundtable is back and, this time, we are exploring what the biggest strategy shifts will be.

The panel will include:

Liz Gilbert, Gettin Local

Michael Merle, Guerdon

James Larounis, Upgraded Points

Galit Schwarz,  UR Social Club

Make sure to follow along for future roundtables. On Monday, June 28th, we will be diving into how automation is charting a new course for aerospace.

I’ll be back next Monday for The Weekly Scale but, until then, if you know of a story that you want us to cover, let us know with the hashtag B2BNeverSleeps.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscalew

Follow us on social media for the latest updates in B2B!

Image

Latest

cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More
organoids
Growing the Future of Cancer Research: Inside the Promise of Organoids
April 19, 2025

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Read More
Immuno-Oncology
Shaping the Future of Cancer Care Through Immuno-Oncology
April 19, 2025

In the ever-evolving world of cancer treatment, immuno-oncology (IO) continues to stand at the forefront of innovation. With recent FDA approvals for TIL therapies and bispecific antibodies, and new developments in CAR-T technologies, the field is rapidly expanding into combination-based strategies that integrate with standard care. Researchers are also exploring how to overcome challenges posed…

Read More